1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 18 MAY 2015

CNS Drug News 18 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - J&J's Invega Franchise Will Remain A Blockbuster
Industry Brief - Zambon Launches Xadago For Mid- To Late-Stage PD In Germany
Industry Brief - FDA Lifts Clinical Hold On NeuroDerm's SC Delivered Levodopa/Carbidopa For PD
Industry Trend Analysis - Hot Topics In MS: Progressive Disease And Remyelination
Industry Brief - Retrophin's RE-024 Receives FDA ODD For PKAN
Industry Brief - THR-18 Reduces ICH/Brain Oedema And Enhances Recovery In AIS Patients
Industry Brief - SDP/Takeda To Terminate Agreement For Latuda In Europe
Industry Brief - FDA Issues CRL To sNDA Seeking To Expand Invega Sustenna's Label
Industry Brief - Indivior Reports Positive Top-Line Results From RBP-7000 Phase III Trial In Schizophrenia
Industry Brief - Curemark Launches Phase III Trial In Expanded Population Of Children With Autism
Industry Brief - Pernix Launches Zohydro ER With BeadTek
Industry Brief - FDA Approves Treximet For Use In Paediatric Patients
Industry Brief - Teva Presents Further Data From Phase IIb With TEV-48125 In Chronic Migraine
Industry Brief - Amgen's AMG 334 Phase II Study In Episodic Migraine Prevention Meets Primary Endpoint
Industry Brief - Adynxx Completes Enrolment In AYX1 Phase II Study For Post-Surgical Pain Prevention
Industry Brief - US Patent Allowed Covering Relmada's Securel Abuse-Deterrent Technology Platform
Industry Brief - Fycompa Launched In Italy
Industry Brief - GW Initiates Phase II Study Of CBDV In Epilepsy
Industry Brief - SAGE Achieves 77% Response Rate In Completed Phase I/II Trial In SRSE
Industry Brief - GW Initiates Phase III Pivotal Study Of Epidiolex In LGS
Industry Trend Analysis - Orexigen's Shares Slump But Contrave Sales Will Not Follow Suit
Industry Brief - TGA Approves Akynzeo For CINV Prevention
Industry Brief - Acacia Reports Positive Results From Phase II Study With APD403 In CINV
Industry Brief - Arena/Roivant Enter Collaboration For Nelotanserin
Industry Trend Analysis - Lundbeck's Revenue To Remain Stable In 2015
Industry Brief - Teva Completes Acquisition Of Auspex Pharmaceuticals
Industry Brief - GW Closes US Public Offering Raising Approximately USD179.2mn
Industry Brief - Newron Raises Funds To Accelerate Development Of Novel Medicines For Rare CNS Disorders
Industry Brief - CNS Conferences - August 2015

Table Of Contents

CNS Drug News 18 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.